Health product recall

Recall: Teva- Bupropion 300mg - lower strength tablet

Last updated

Summary

Product
TEVA-BUPROPION XL 300MG TABLETS
Issue
Health products - Product quality
What to do

Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.

Distribution
National

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot numbers

Teva

TEVA-BUPROPION XL

DIN 02439662

Tablet (Extended-Release)

BUPROPION HYDROCHLORIDE 300mg

100055815 & 100061092

Issue

 Affected lot may contain the presence of a lower strength tablet.

What you should do

  1. Verify if your product is affected.
  2. Contact the recalling firm if you have any questions about the recall.
  3. Report any health product related side effects to Health Canada.
  4. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Retailers

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

Teva Canada Limited

30 Novopharm Court

Toronto, ON

M1B 2K9

Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
National
Recall class
Type II
Identification number
RA-75907

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe